Biosecurity
More on Biosecurity
WASHINGTON DC — Chairman John Moolenaar (R-MI), Ranking Member Raja Krishnamoorthi (D-IL), and Rep. Neal Dunn (R-FL) of the House Select Committee on the Chinese Communist Party wrote to Secretary of Commerce Gina Raimondo, urging the Department to update its regulations to require a license prior to engaging with a Chinese military hospital for clinical trials.
Chairman John Moolenaar (R-MI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party joined Rep. Dan Newhouse (R-WA) and Rep. Jake Auchincloss (D-MA), co-leads of the Committee’s Fentanyl Policy Working Group, to introduce bipartisan legislation that helps hold China responsible for the fentanyl crisis.
WATCH: Lawmakers on the Select Committee' Fentanyl Policy Working Group unveil new bipartisan legislation in the working group's last meeting of the 118th Congress.
Chairman Rep. John Moolenaar's remarks, as prepared for delivery, at the final meeting of the Select Committee's Fentanyl Working Group.
Click HERE to read the full remarks.
Chairman John Moolenaar (R-MI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party requested information from the FDA about the alarming practice of U.S. biopharmaceutical companies conducting clinical trials alongside the People’s Liberation Army (PLA) and in Xinjiang, where the CCP is engaged in genocide of the Uyghur people. Reps. Neal Dunn, M.D.
Chairman John Moolenaar (R-MI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party requested information from the FDA about the alarming practice of U.S. biopharmaceutical companies conducting clinical trials alongside the People’s Liberation Army (PLA) and in Xinjiang, where the CCP is engaged in genocide of the Uyghur people. Reps. Neal Dunn, M.D.
WASHINGTON D.C. -- Chairman John Moolenaar (R-MI) of the House Select Committee on the Chinese Communist Party wrote to Secretary of Agriculture Tom Vilsack, inquiring why the U.S. Department of Agriculture greenlit a Chinese agricultural biotech company with close links to the Chinese government operating in the United States. The firm, Qi Biodesign, is a company that makes genetically engineered soybean seeds and was prioritized for USDA regulatory approval ahead of many American agricultural companies that currently face extensive delays.
|
Chairman John Moolenaar (R-MI), and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on Strategic Competition Between the United States and the Chinese Communist Party, sent a letter to Federal Bureau of Investigation (FBI) Director Christopher Wray and Director of National Intelligence (DNI) Avril Haines requesting a briefing on a People’s Republic of China (PRC) biotech firm GenScript Biotechnology and its three main business segments — Bestzyme, Legend Biotech, and ProBio — for their ties to the Chinese Communist Party (
